Searched over 200M research papers
10 papers analyzed
These studies suggest that metastatic cancer symptoms commonly include pain, fatigue, and psychological distress, with specific symptoms varying by cancer type and stage, and symptom management requiring ongoing patient and family discussions.
20 papers analyzed
Pain and fatigue are among the most frequently reported symptoms in patients with metastatic cancer. Studies have shown that cancer pain is prevalent in a significant portion of patients, with reports indicating that 38% to 81% of patients experience pain depending on the data source. Fatigue is also a common symptom, affecting up to 89% of patients. These symptoms are often severe and can significantly impact the quality of life .
Gastrointestinal issues such as nausea, vomiting, and loss of appetite are also commonly reported. In a study of patients with metastatic breast cancer, nausea was reported by 32% of patients, and decreased appetite by 22%. Similarly, vomiting and loss of appetite were significant symptoms in patients with metastatic cancer, with odds ratios of 3.5 and 4.0, respectively, when compared to cancer controls.
Shortness of breath is another symptom frequently associated with metastatic cancer. It was notably reported in patients with metastatic breast cancer and was one of the symptoms showing a significant relationship with tumor response. Additionally, shortness of breath was among the top five symptoms reported by patients with metastatic disease over a 16-week period.
Psychological symptoms such as anxiety, depression, and mood disturbances are also prevalent. Studies have highlighted that these symptoms are significant and often require management to improve the patient's overall well-being . Mindfulness has been associated with lower levels of pain, fatigue, and psychological distress, suggesting it could be a beneficial intervention for these patients.
Research has identified various symptom clusters in patients with metastatic cancer. These clusters often include combinations of pain, fatigue, depression, and insomnia . The identification of these clusters is crucial for developing targeted symptom management strategies.
Effective management of these symptoms often involves a combination of pharmacological and non-pharmacological approaches. For instance, palliative chemotherapy has been shown to improve symptoms such as pain and shortness of breath in patients who respond to treatment. Additionally, remote symptom management programs have been effective in documenting symptoms in real-time and providing timely interventions.
The severity of symptoms can also have prognostic implications. For example, in metastatic prostate cancer, symptoms like bladder outflow obstruction, bone pain, and anemia not only dictate treatment selection but also have significant prognostic value. Similarly, in metastatic gastric cancer, symptoms such as tiredness and lack of appetite were prevalent and severe, particularly towards the end of life.
The symptom burden can vary significantly between different types of metastatic cancer. For instance, patients with metastatic lung cancer often experience severe symptoms such as cough and respiratory distress, which worsen in the final months of life. In contrast, patients with metastatic breast cancer may experience a broader range of symptoms, including psychological distress and sleep disturbances.
Metastatic cancer is associated with a high symptom burden that significantly impacts patients' quality of life. Common symptoms include pain, fatigue, gastrointestinal issues, respiratory symptoms, and psychological distress. Effective management of these symptoms requires a comprehensive approach that includes both pharmacological and non-pharmacological strategies. Understanding the prognostic significance of these symptoms can also aid in better treatment planning and improving patient outcomes.
Most relevant research papers on this topic